Skip to content

Harmony Biosciences Holdings, Inc. HRMY Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
Biohaven logo
BiohavenBHVN
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.99B-14.9%

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s accrued manufacturing costs?
Harmony Biosciences Holdings, Inc. (HRMY) reported accrued manufacturing costs of $6.73M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s accrued manufacturing costs changed year-over-year?
Harmony Biosciences Holdings, Inc.'s accrued manufacturing costs decreased by 11.3% year-over-year, from $7.58M to $6.73M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s accrued manufacturing costs?
Over 3 years (2022 to 2025), Harmony Biosciences Holdings, Inc.'s accrued manufacturing costs has grown at a 16.9% compound annual growth rate (CAGR), from $11.53M to $18.44M.